Cellular processing of platinum anticancer drugs

@article{Wang2005CellularPO,
  title={Cellular processing of platinum anticancer drugs},
  author={D. Wang and S. Lippard},
  journal={Nature Reviews Drug Discovery},
  year={2005},
  volume={4},
  pages={307-320}
}
Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in cancer chemotherapy. Platinum–DNA adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs. This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signalling of DNA damage, cell-cycle… Expand
2,654 Citations
Inhibition of transcription by platinum antitumor compounds.
  • 393
Understanding and improving platinum anticancer drugs--phenanthriplatin.
  • 193
Cellular Responses to Cisplatin-Induced DNA Damage
  • 306
  • PDF
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.
  • 379
Action of the anticancer drug cisplatin investigated by molecular simulation
  • Highly Influenced
  • PDF
Understanding and Improving Platinum Anticancer Drugs
  • 1
Monofunctional Platinum(II) Anticancer Agents
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 234 REFERENCES
Recognition of cisplatin adducts by cellular proteins.
  • 309
Cellular and molecular pharmacology of oxaliplatin.
  • 443
Current status of the development of trans-platinum antitumor drugs.
  • 103
Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes.
  • A. Eastman
  • Chemistry, Medicine
  • Chemico-biological interactions
  • 1987
  • 139
Protein interactions with platinum-DNA adducts: from structure to function.
  • 87
Decreased cisplatin uptake by resistant L1210 leukemia cells.
  • 68
...
1
2
3
4
5
...